Title:
P95HER2 ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143322
Kind Code:
A1
Abstract:
Provided are a p95HER2 antibody and use thereof, and specifically an antibody or an antigen-binding fragment that specifically binds to human p95HER2, a corresponding multi-specific antibody or an antigen-binding fragment, an antibody-drug conjugate, a nucleic acid, a vector, a cell, a composition, a preparation method, a pharmaceutical use, a treatment method, a detection method, and a corresponding kit, which are of great significance to a p95HER2-related treatment or detection.
Inventors:
MA XIAOLI (CN)
MA HUAIYUAN (CN)
FU YAYUAN (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
MA HUAIYUAN (CN)
FU YAYUAN (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2023/072966
Publication Date:
August 03, 2023
Filing Date:
January 18, 2023
Export Citation:
Assignee:
SHANDONG SIMCERE BIOPHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/30; A61K39/395; A61P35/00; C07K16/46; C12N15/13; C12N15/62; C12N15/63; G01N33/577
Domestic Patent References:
| WO2021239965A1 | 2021-12-02 |
Foreign References:
| CN109843926A | 2019-06-04 | |||
| US20110135653A1 | 2011-06-09 | |||
| US20100143927A1 | 2010-06-10 |
Other References:
ARRIBAS JOAQUÍN, BASELGA JOSÉ, PEDERSEN KIM, PARRA-PALAU JOSEP LLUÍS: "p95HER2 and Breast Cancer", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 71, no. 5, 1 March 2011 (2011-03-01), US, pages 1515 - 1519, XP093081367, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-10-3795
Attorney, Agent or Firm:
BEIJING HUIZHENG LAW OFFICE (CN)
Download PDF: